Who Owns ENLV?

Enlivex Therapeutics Ltd. — Institutional Ownership & 13F Holdings

$0.90

+0.01 (+0.71%)

Market Cap

$28.2M

Shares Outstanding

24,303,070

Institutional Holders

25

Total Inst. Value

$3.1M

% of Float Held

QoQ Holder Change

+10

Institutional data as of Q1 2025

New Positions

5

Closed Positions

3

Increased

5

Decreased

7

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ARMISTICE CAPITAL, LLC$1.7M1,781,931
2MILLENNIUM MANAGEMENT LLC$649K669,008
3MORGAN STANLEY$222K230,685
4RENAISSANCE TECHNOLOGIES LLC$176K181,289
5JANE STREET GROUP, LLC$78K80,759
6CITADEL ADVISORS LLCNew$68K70,136
7TWO SIGMA SECURITIES, LLC$28K28,390
8SIGMA INVESTMENT COUNSELORS INC$27K28,000
9Virtu Financial LLCNew$17K17,451
10Neuberger Berman Group LLCNew$14K14,000

Biggest Buyers & Sellers This Quarter

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold ENLV?

As of Q1 2025, 25 institutional investors report holding ENLV (Enlivex Therapeutics Ltd.) in their 13F filings.

Which hedge fund owns the most ENLV?

The largest institutional holder of ENLV is ARMISTICE CAPITAL, LLC with $1.7M in shares.

Are institutions buying or selling ENLV?

This quarter, 5 institutions opened new positions in ENLV and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.